Sfoglia per RIVISTA
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Collezione AOU Città della Salute di Torino
Items : 4
New drugs in early development for treating multiple myeloma: all that glitters is not gold. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2020 Sep;29(9):989-1004. doi: 10.1080/13543784.2020.1772753. Epub 2020 S
2020
AOU Città della Salute di Torino
Bertamini L; Bonello F; Boccadoro M; Bringhen S;
Melflufen for relapsed and refractory multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2020 Oct;29(10):1069-1078. doi: 10.1080/13543784.2020.1808884. Epub 2020
2020
AOU Città della Salute di Torino
Oriol A; Larocca A; Leleu X; Hajek R; Hassoun H; Rodríguez-Otero P; Paner A; Schjesvold FH; Gullbo J; Richardson PG;
Novel investigational drugs active as single agents in multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2017 Jun;26(6):699-711. doi: 10.1080/13543784.2017.1324571. Epub 2017 Ma
2017
AOU Città della Salute di Torino
D'Agostino M; Salvini M; Palumbo A; Larocca A; Gay F;
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2014 Sep;23(9):1193-209. doi: 10.1517/13543784.2014.920821. Epub 2014 Ju
2014
AOU Città della Salute di Torino
Bringhen S; Gay F; Donato F; Troia R; Mina R; Palumbo A;